Martin Fessenmaier, Ph.D.
Mr. Fessenmaier graduated from the University of Karlsruhe, Germany, with a M.S. in Biology with a focus on genetics, physiology, biochemistry and organic chemistry. He received his Ph.D. in Biochemistry/Molecular
Biology in 1993 magna cum laude at the University of Karlsruhe, Germany, and was awarded in 1994 a DFG research grant for a postdoctoral fellowship at the Scripps Research Institute in La Jolla, California. After completion of his post doctoral fellowship, Mr. Fessenmaier took on the position of a project leader in a San Diego biotechnology firm, developing various diagnostic test kits for analytes from biological fluids.
Mr. Fessenmaier joined Fish & Associates as a scientific consultant in January 1999 and was admitted to represent clients before the USPTO in September 2000. In January 2002, Fish & Associates joined Rutan and Tucker until March 2007, when Fish & Associates took up practice again as a IP boutique firm in Orange county.
Since then, Mr. Fessenmaier continued to apply his extensive expertise in preparation and prosecution of national and international patent applications, patentability and infringement opinions, patent portfolio analysis and strategy, and direction of foreign associates in prosecution of international patent applications. Mr. Fessenmaier represented numerous corporate and individual inventors, predominantly in the fields of organic chemistry, biochemistry, molecular biology, pharmaceutical chemistry, medical devices, electrochemistry, chemical engineering, and general mechanical arts. Clients representative of Mr. Fessenmaier's practice include AutoGenomics, Fluor Corporation, Honeywell International, ICN Pharmaceuticals, Performance Fibers, Ribapharm, and the University of California Irvine.
A further focus of his practice is educating current and prospective clients to identify patentable subject matter from an invention- and market-oriented perspective, and to work with his clients to maintain alignment of claim coverage with the often fluid market demands and new product developments.